Clinical Trial Update: Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial updates safety and efficacy of IDP-118 in treating plaque psoriasis; results posted after completion in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• IDP-118 (IDP-118)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2020-08-20